Honglian Gui

924 total citations
27 papers, 494 citations indexed

About

Honglian Gui is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Honglian Gui has authored 27 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 16 papers in Hepatology and 3 papers in Infectious Diseases. Recurrent topics in Honglian Gui's work include Hepatitis B Virus Studies (17 papers), Liver Disease Diagnosis and Treatment (14 papers) and Hepatitis C virus research (12 papers). Honglian Gui is often cited by papers focused on Hepatitis B Virus Studies (17 papers), Liver Disease Diagnosis and Treatment (14 papers) and Hepatitis C virus research (12 papers). Honglian Gui collaborates with scholars based in China, Australia and United States. Honglian Gui's co-authors include Qing Xie, Hui Wang, Shisan Bao, Simin Guo, Qing Guo, Xiaogang Xiang, Wei Cai, Qing Xie, Huijuan Zhou and Henry Lik‐Yuen Chan and has published in prestigious journals such as Hepatology, Journal of Clinical Microbiology and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Honglian Gui

24 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Honglian Gui China 13 340 306 107 55 51 27 494
Lingyao Du China 12 314 0.9× 286 0.9× 55 0.5× 119 2.2× 51 1.0× 60 489
Ruyi Guo China 10 197 0.6× 146 0.5× 89 0.8× 56 1.0× 28 0.5× 20 336
Y‐F Liaw Taiwan 12 583 1.7× 648 2.1× 120 1.1× 65 1.2× 62 1.2× 20 840
Erwin Daniel Brenndörfer Sweden 13 202 0.6× 250 0.8× 151 1.4× 91 1.7× 41 0.8× 22 442
Marianne Eisenhardt Germany 8 203 0.6× 235 0.8× 247 2.3× 32 0.6× 33 0.6× 11 422
Arshi Khanam United States 14 383 1.1× 390 1.3× 140 1.3× 74 1.3× 91 1.8× 23 660
Marzia Margotti Italy 10 317 0.9× 323 1.1× 49 0.5× 34 0.6× 80 1.6× 19 449
Gangde Zhao China 12 267 0.8× 211 0.7× 63 0.6× 34 0.6× 14 0.3× 28 363
Paul David Germany 11 183 0.5× 177 0.6× 106 1.0× 101 1.8× 31 0.6× 23 440

Countries citing papers authored by Honglian Gui

Since Specialization
Citations

This map shows the geographic impact of Honglian Gui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Honglian Gui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Honglian Gui more than expected).

Fields of papers citing papers by Honglian Gui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Honglian Gui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Honglian Gui. The network helps show where Honglian Gui may publish in the future.

Co-authorship network of co-authors of Honglian Gui

This figure shows the co-authorship network connecting the top 25 collaborators of Honglian Gui. A scholar is included among the top collaborators of Honglian Gui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Honglian Gui. Honglian Gui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yang, Honglian Gui, Daoli Zhang, et al.. (2025). High-performance near-Infrared computational spectrometer enabled by finely-tuned PbS quantum dots. Nano Research. 18(5). 94907351–94907351.
2.
Gui, Honglian, Yan Shen, Lin Tan, et al.. (2025). Interim Analysis of 48-week Tenofovir Amibufenamide Treatment in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase Levels: The PROMOTE Study. Journal of Clinical and Translational Hepatology. 0(0). 0–0.
3.
4.
Li­, ­Jun, Zhanqing Zhang, Weifeng Zhao, et al.. (2023). Factors associated with persistent positive in HBV DNA level in patients with chronic Hepatitis B receiving entecavir treatment. Frontiers in Cellular and Infection Microbiology. 13. 1151899–1151899. 3 indexed citations
5.
Sun, Jingyuan, Pei Li, Honglian Gui, et al.. (2023). Deacetylation via SIRT2 prevents keratin-mutation-associated injury and keratin aggregation. JCI Insight. 8(14). 2 indexed citations
6.
Cao, Zhujun, Zi-Ke Sheng, Xiaogang Xiang, et al.. (2022). COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status. Infectious Diseases of Poverty. 11(1). 56–56. 12 indexed citations
7.
8.
Gui, Honglian, et al.. (2021). Autoimmune liver disease-associated serologic profiling in Chinese patients with acute hepatitis E virus infection. Immunologic Research. 69(1). 81–89. 5 indexed citations
9.
Gui, Honglian, Yan Huang, Gangde Zhao, et al.. (2021). External Validation of aMAP Hepatocellular Carcinoma Risk Score in Patients With Chronic Hepatitis B-Related Cirrhosis Receiving ETV or TDF Therapy. Frontiers in Medicine. 8. 677920–677920. 12 indexed citations
10.
Lu, Jie, Qing Li, Jiayuan Jiang, et al.. (2021). Laboratory-based Surveillance and Clinical Profile of Sporadic HEV Infection in Shanghai, China. Virologica Sinica. 36(4). 644–654. 10 indexed citations
11.
Gui, Honglian, Changqing Zhao, Yan Wang, et al.. (2020). Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis. Journal of Clinical and Translational Hepatology. 8(3). 1–8. 14 indexed citations
12.
Sun, Jingyuan, Vincent E. Groppi, Honglian Gui, et al.. (2015). High-Throughput Screening for Drugs that Modulate Intermediate Filament Proteins. Methods in enzymology on CD-ROM/Methods in enzymology. 568. 163–185. 15 indexed citations
13.
Lai, Rongtao, Xiaogang Xiang, Ruidong Mo, et al.. (2015). Protective effect of Th22 cells and intrahepatic IL-22 in drug induced hepatocellular injury. Journal of Hepatology. 63(1). 148–155. 47 indexed citations
14.
Toy, Mehlika, Joshua A. Salomon, Hao Jiang, et al.. (2013). Population Health Impact and Cost-Effectiveness of Monitoring Inactive Chronic Hepatitis B and Treating Eligible Patients in Shanghai, China. Hepatology. 60(1). 46–55. 36 indexed citations
15.
Xiang, Xiaogang, Honglian Gui, Nicholas J. C. King, et al.. (2011). IL‐22 and non‐ELR‐CXC chemokine expression in chronic hepatitis B virus‐infected liver. Immunology and Cell Biology. 90(6). 611–619. 54 indexed citations
16.
Lin, Lingnan, Vincent Wai‐Sun Wong, Huijuan Zhou, et al.. (2010). Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg‐negative patients. Journal of Medical Virology. 82(9). 1494–1500. 53 indexed citations
17.
Gui, Honglian, Haowei Wang, Yun Wu, et al.. (2010). Significant histopathology in Chinese chronic hepatitis B patients with persistently high–normal alanine aminotransferase. Journal of Viral Hepatitis. 17(s1). 44–50. 48 indexed citations
18.
Xie, Qing, Hui Wang, Honglian Gui, et al.. (2009). Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9. Microbes and Infection. 11(4). 515–523. 74 indexed citations
19.
Gui, Honglian, Chunfang Gao, Hui Wang, et al.. (2009). Altered serumN-glycomics in chronic hepatitis B patients. Liver International. 30(2). 259–267. 28 indexed citations
20.
Gui, Honglian & Qing Xie. (2007). [Diagnosis, management and prevention of hepatitis B virus reactivation during anticancer therapy].. PubMed. 15(1). 78–80.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lingyao Du Breakdown of academic impact, for papers by Ruyi Guo Breakdown of academic impact, for papers by Y‐F Liaw Breakdown of academic impact, for papers by Erwin Daniel Brenndörfer Breakdown of academic impact, for papers by Marianne Eisenhardt Breakdown of academic impact, for papers by Arshi Khanam Breakdown of academic impact, for papers by Marzia Margotti Breakdown of academic impact, for papers by Gangde Zhao Breakdown of academic impact, for papers by Paul David
Rankless by CCL
2026